Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1982)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (411)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2093)
  2. Meeting Abstract (2072)
  3. Book Section (179)
  4. Review (88)
  5. Editorial (80)
  6. Guidelines (35)
  7. Correspondence (24)
  8. Book Whole (17)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1982)
  2. Solid Tumor Oncology Division (1615)
  3. GSK Faculty (761)
  4. Survivorship Research (635)
  5. Population Sciences Research Program (612)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (65)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1666)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engaging stakeholders to address anxiety in Latino/a caregivers of older adults with cancer
    Meeting Abstract

    McConnell, K.; Gilliland, J.; Salner, A.
    Innovation in Aging (2024)

    Fulltext@MSK | Save
  • Optimizing a pragmatic trial of emergency department initiated care for persons living with dementia
    Meeting Abstract

    Brody, A.; Shah, M.; Goldfeld, K.; Grudzen, C.; Chodosh, J.
    Innovation in Aging (2024)

    Fulltext@MSK | Save
  • Examining age bias in ChatGPT responses to user questions about decision-making in advanced cancer
    Meeting Abstract

    McDarby, M.; Mroz, E.; Hahne, J.; Carpenter, B.; Parker, P.
    Innovation in Aging (2024)

    Fulltext@MSK | Save
  • An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2
    Meeting Abstract

    Lee, J. Y.; Makker, V.; Oaknin, A.; Oh, D. Y.; Anoka, C.; Jung, L.; Simoes, J.; Puvvada, S. D.; Meric-Bernstam, F.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of davutamig (REGN5093), a METxMET bispecific antibody, in patients with MET-altered, advanced non-small cell lung cancer (aNSCLC): Trial in progress update
    Meeting Abstract

    Ahn, M. J.; Cho, B.; Kim, T. M.; Han, J. Y.; Kim, C.; Shim, B.; Drilon, A.; Blumenschein, G.; Villaruz, L.; Gray, J. E.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with adult-type diffuse glioma with an IDH1/2 mutation (INDIGO): Updated efficacy results
    Meeting Abstract

    Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Blumenthal, D. T.; Peters, K. B.; Ellingson, B. M.; Clarke, J. L.; Mendez, J.; Yust-Katz, S.; Mason, W. P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Long-term efficacy and safety of larotrectinib in patients with TRK fusion primary central nervous system (CNS) tumors: An updated analysis
    Meeting Abstract

    Perreault, S.; Spano, J. P.; Nilsson, A.; Deyell, R. J.; Doz, F.; Geoerger, B.; Gumus, M.; Lassen, U. N.; Nysom, K.; Valero-Arrese, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of paxalisib in GBM AGILE phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Mellinghoff, I. K.; Cloughesy, T.; Alexander, B.; Berry, D. A.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B. M.; Gordon, G. B.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)
    Meeting Abstract

    Hwang, E.; Kilburn, L.; Mitchell, D.; Lin, T.; Poussaint, T. Y.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy of AZD1390 + radiation therapy for glioblastoma
    Meeting Abstract

    Wen, P.; Yang, J. T.; Imber, B. S.; Drappatz, J.; Jena, R.; Forst, D.; Zukas, A.; Short, S. C.; Fan, C.; Trigg, W.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save